Abstract:AIM:To study the release and cell uptake characteristics of 9-nitrocamptothecin (9-NC) nanostructured lipid carrier system (NLC) in vitro and its tissue distribution characteristics in vivo.METHODS:Mouse peritoneal macrophages were used to investigate the uptake of nanoparticles by cells in vitro. The tissue distribution of 9-nitrocamptothecin solution and stealth nanostructured lipid carrier system (S-NLC) was determined after intravenous administration to mice at a single dose of 1.5 mg kg(-1). The release and crystalloid characteristics were also investigated.RESULTS:X-ray diffraction spectrum showed that 9-NC probably was amorphous in S-NLC. The liquid lipid did not change the characteristics of the solid matrix in nanoparticles. The in vitro release and cell uptake characteristics of stealth and non-stealth 9-NC-NLC were investigated, separately. The results showed that the stealth 9-NC-NLC had sustained-release characteristics and could resist the absorption effect of the additional plasmas to a certain extent. In addition, the cell uptake percentage of stealth 9-NC-NLC was much lower than that of the non-stealth ones. The tissues distribution results showed that 9-NC in the S-NLC was mainly found in the lung, liver, pancreas and ovary/uterus, while the quantity of 9-NC was much lower in heart and kidney. The AUQ(0-t), of S-NLC in blood, ovary/uterus, pancreas, liver and lung were higher than that of 9-nitrocamptothecin solution. The weight-average drug targeting efficiency (Te*) of S-NLC in liver and lung were significantly higher than that of 9-nitrocamptothecin solution. The mean residence times (MRT) of S-NLC was 44 h, while that of 9-nitrocamptothecin solution was 8 h. Therefore, S-NLC showed obvious targeting effects on liver and lung.CONCLUSION:S-NLC with PEG flexible chains has sustained-release characteristics and can prolong its circulation in blood and have good targeting efficiency on liver and lung.

Biliary Excretion of 9-Nitrocamptothecin after Intravenous Administration of 9-Nitrocamptothecin Liposome to Rats

Pharmacokinetics and Urinary Excretion of 9-Nitrocamptothecin Following Intravenous Administration of Lactone and Carboxylate Forms to Rats

Preparation of 9-Nitrocamptothecin Liposome and Its Pharmacokinetic after Pulmonary Delivery to Rats

Biodistribution in Mice and Severity of Damage in Rat Lungs Following Pulmonary Delivery of 9-Nitrocamptothecin Liposomes

Disposition of 9-nitrocamptothecin after sigle oral dose in rats

[9-Nitrocamptothecin Nanostructured Lipid Carrier System: in Vitro Releasing Characteristics, Uptake by Cells, and Tissue Distribution in Vivo].

Pharmacokinetics and Tissue Distribution in Tumor-bearing Mice After iv Administration of 9-Nitrocamptothecin with Different Lactone Ratios

Effect of Tween80 on the Pharmacokinetics of 9-nitrocamptothecin Liposome

Preparation of 9-Nitrocamptothecin Self-Emulsified Microemulsion and Its Pharmacokinetics in Rats

[The in Vitro Kinetics of Uptake, Transport and Efflux of 9-Nitrocamptothecin in Caco-2 Cell Model].

Complex of 9-nitro-camptothecin in hydroxypropyl-β-cyclodextrin: In vitro and in vivo evaluation

Protection Effect of Self-Emulsifying Microemulsion on 9-Nitrocamptothecin Lactone Form

[Luteolin Excretion after Oral Administration of Elsholtzia Blanda Benth Extracts in Rats].

Optimization of Solid-Phase Extraction and Liquid Chromatography-Tandem Mass Spectrometry for Simultaneous Determination of Capilliposide B and Its Active Metabolite in Rat Urine and Feces: Overcoming Nonspecific Binding.

Determination of 9-Nitrocamptothecin in Rat Plasma by Reversed Phase High Performance Liquid Chromatography

Enhanced anti-tumor effect of 9-nitro-camptothecin complexed by hydroxypropyl-β-cyclodextrin and safety evaluation.

Determination of Lactone and the Total of Lactone and Carboxylate Forms of 9- Nitrocamptothecin in Human Plasma by HPLC

In Vitro Metabolism of E2, G2: Novel Bile Acid-Coupling Camptothecin Analogues, in Rat Liver Microsomes

Study on the Protection of Self-Emulsification Microemulsion Tolactone Structure of 9-Nitrocamptothecin

Transport characteristics of 9-nitrocamptothecin in the human intestinal cell line Caco-2 and everted gut sacs.

Preparation of 9-Nitrocamptothecin Self-Emulsification Microemulsion and in Vitro Cytotoxicity Evaluation